INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 150 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,490,000 | +35.7% | 87,213 | +8.5% | 0.00% | 0.0% |
| Q4 2018 | $1,098,000 | -76.2% | 80,417 | -50.0% | 0.00% | -33.3% |
| Q3 2018 | $4,604,000 | +184.5% | 160,834 | +172.0% | 0.00% | +50.0% |
| Q2 2018 | $1,618,000 | +98.5% | 59,131 | +53.0% | 0.00% | +100.0% |
| Q1 2018 | $815,000 | +32.7% | 38,650 | +21.0% | 0.00% | 0.0% |
| Q4 2017 | $614,000 | -5.2% | 31,950 | +22.4% | 0.00% | 0.0% |
| Q3 2017 | $648,000 | +55.4% | 26,094 | +0.1% | 0.00% | 0.0% |
| Q2 2017 | $417,000 | +167.3% | 26,070 | +135.3% | 0.00% | – |
| Q1 2017 | $156,000 | +8.3% | 11,079 | +0.8% | 0.00% | – |
| Q4 2016 | $144,000 | -23.0% | 10,990 | 0.0% | 0.00% | – |
| Q3 2016 | $187,000 | -20.4% | 10,990 | 0.0% | 0.00% | – |
| Q2 2016 | $235,000 | – | 10,990 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |